Why is RPG Life Sciences Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0 times
2
Poor long term growth as Net Sales has grown by an annual rate of 12.11% over the last 5 years
3
Flat results in Sep 26
- ROCE(HY) Lowest at 24.06%
- PAT(Q) At Rs 26.60 cr has Fallen at -8.8% (vs previous 4Q average)
4
Stock is technically in a Mildly Bullish range
- The technical trend has improved from Sideways on 16-Nov-26 and has generated -2.04% returns since then
- A key technical factor - MACD has been Bullish since 16 Nov 2026
5
With ROE of 18, it has a Fair valuation with a 6.7 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 13.96%, its profits have risen by 0% ; the PEG ratio of the company is 37.4
6
Increasing Participation by Institutional Investors
- Institutional investors have increased their stake by 1.17% over the previous quarter and collectively hold 10.8% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
How much should you hold?
- Overall Portfolio exposure to RPG LifeScience. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is RPG LifeScience. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
RPG LifeScience.
13.96%
0.30
46.25%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
12.11%
EBIT Growth (5y)
13.63%
EBIT to Interest (avg)
98.43
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.28
Sales to Capital Employed (avg)
1.48
Tax Ratio
24.69%
Dividend Payout Ratio
21.66%
Pledged Shares
0
Institutional Holding
10.80%
ROCE (avg)
40.92%
ROE (avg)
21.08%
Valuation Key Factors 
Factor
Value
P/E Ratio
36
Industry P/E
40
Price to Book Value
6.73
EV to EBIT
31.65
EV to EBITDA
26.85
EV to Capital Employed
8.92
EV to Sales
5.36
PEG Ratio
37.39
Dividend Yield
0.95%
ROCE (Latest)
28.18%
ROE (Latest)
18.00%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
Technical Movement
3What is working for the Company
NET SALES(Q)
Highest at Rs 211.64 cr
-4What is not working for the Company
ROCE(HY)
Lowest at 24.06%
PAT(Q)
At Rs 26.60 cr has Fallen at -8.8% (vs previous 4Q average
Loading Valuation Snapshot...
Here's what is working for RPG LifeScience.
Net Sales - Quarterly
Highest at Rs 211.64 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for RPG LifeScience.
Profit After Tax (PAT) - Quarterly
At Rs 26.60 cr has Fallen at -8.8% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 29.17 CrMOJO Watch
Near term PAT trend is negative
PAT (Rs Cr)